06-Feb-2020 | Facts and Factors
Facts and Factors has authored “Global Dental Anticoagulants Market By Drug Class (DOACs, Vitamin K Antagonist, Heparin, and Others), By Route of Administration (Oral Anticoagulants and Injectable Anticoagulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Regions: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026”. Based on our analysis, the global Dental Anticoagulants market in 2019 is approximately USD 2,050 Million and is anticipated to reach around USD 3,155 Million by 2026. The anticipated CAGR for the global Dental Anticoagulants market is around 6.3 % from 2020 to 2026.
Introduction
Blood thinners are also known as anticoagulant drugs. These are chemical substances used to stop or reduce coagulation of blood and instead extend the time of blood clotting. Anticoagulant drugs are generally used in cases of severe medical conditions where the risk of blood clots is higher. These drugs can be administered orally or intravenously in case of heart attack, pulmonary embolism, etc. The anticoagulants are present in the sample tubes, blood transfusion bags, and other medical devices. Anticoagulant drugs, especially direct anticoagulants, play an important role in case of dental invasive treatments and surgeries where hemostasis is known to play a vital role.
Browse the full “Global Dental Anticoagulants Market By Drug Class (DOACs, Vitamin K Antagonist, Heparin, and Others), By Route of Administration (Oral Anticoagulants and Injectable Anticoagulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Regions: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” report at https://www.fnfresearch.com/global-dental-anticoagulants-market-by-drug-class-doacs
Drivers of the global Dental Anticoagulants Market:
Direct oral anticoagulants (DOACs) are widely used anticoagulants due to their easy use and excellent safety profile. They have set doses and do not require regular international standardizations. Thus, the high demand for DOACs owing to their safety is expected to drive the global Dental Anticoagulants market over the forecast period.
- Rising healthcare expenses on a global level
The growing occurrence of severe disorders such as diabetes, cardiovascular diseases, cancer, etc. along with technological innovations is likely to surge the Dental Anticoagulants market. In addition, the increasing expenditure on research and development will further supplement the growth of the market. The rising number of the older population, high labor costs, and high supply & demand will further propel the market during the forecast timeframe. Likewise, growing healthcare awareness and disposable income are anticipated to drive the market growth.
Restraints of the Dental Anticoagulants Market:
- Complications associated with Anticoagulant
- Stringent regulatory requirements
Opportunities for the Dental Anticoagulants Market:
The development of new anticoagulants especially direct oral anticoagulants and novel oral anticoagulants are likely to help increase boost the market growth due to their higher efficacy and safety profile. The novel alternative anticoagulants are expected to open new doors of opportunities for the Dental Anticoagulants market.
Market Segment Dominance:
The DOACs category held the majority of the market share in 2018 and will grow owing to the rising demand for oral anticoagulants. Likewise, in 2018, the oral anticoagulants route of administration held major shares of the Dental Anticoagulants market. In the distribution channel segment, the hospital pharmacies category seized high market value in 2018.
Regional Dominance:
North America is expected to dominate the global Dental Anticoagulants market owing to the leading anticoagulants market in the U.S. and rising healthcare setup plus the demand for new therapeutics. The presence of expert healthcare professionals and top market players will further support market growth.
Key Market Players:
Some of the key players in the global Dental Anticoagulants market are Daiichi Sankyo Company, Limited, Sanofi S.A, Aspen Holdings, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Pfizer, Inc., Abbott, Portola Pharmaceuticals, Inc., and Mylan N.V.
Recent Developments:
BMS and Janssen signed an agreement for the manufacturing and marketing of a Factor Xia program consisting of BMS’s Factor XIa inhibitor, BMS986177, which is an experimental anticoagulant compound being scrutinized for the treatment of major thrombotic conditions.
The global Dental Anticoagulants market is segmented into:
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 2,050 Million |
Projected Market Size in 2026 |
USD 3,155 Million |
CAGR Growth Rate |
6.3% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Daiichi Sankyo Company, Limited, Sanofi S.A, Aspen Holdings, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Pfizer, Inc., Abbott, Portola Pharmaceuticals, Inc. , and others. |
Key Segment |
By Drug Class, Route of Administration,Distribution Channel, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Global Dental Anticoagulants Market: By Drug Class
- DOACs (Direct Oral Anticoagulants)
- Apixaban
- Dabigatran
- Rivaroxaban
- Edoxaban
- Others
- Vitamin K Antagonist
- Heparin
- Others
Global Dental Anticoagulants Market: By Route of Administration
- Oral Dental Anticoagulants
- Injectable Dental Anticoagulants
Global Dental Anticoagulants Market: By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Dental Anticoagulants Market: By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle-East and Africa
- GCC Countries
- South Africa
- Rest of Middle-East Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
